Market Overview

For Breast Cancer Awareness Month, Likewise Skincare Promotes the Importance of Daily Skin Care for Reduced Risk of Cancer

Share:

In the midst of Breast Cancer Awareness Month, Likewise Skincare releases statement promoting the importance of daily skin care for a reduced risk of cancer.

Bohemia, NY (PRWEB) October 24, 2012

On October 24, 2012, the skincare brand Likewise Skincare releases a statement promoting the importance of daily skin care for reduced risk of cancer.

October is Breast Cancer Awareness Month and proper skincare is essential to prevent sun damage that can lead to various forms of cancer. Breast cancer is the second most common type of cancer in women, while skin cancer is the number one most common type of cancer among both genders. Likewise Skincare is proud to carry lines of moisturizers targeted to different skin types that not only act as moisturizers and beauty products, but also contain SPF to help protect against sun damage.

According to Likewise Skincare representative Lisa Shariat, “People are very concerned with anti-aging and making sure that they are using the right beauty and skin care products, but it's also essential to make sure that they are being protected from the sun just as much as they are preventing wrinkles. Likewise products provide essential ingredients for anti-aging, promote a glowing complexion and also act as a sunscreen to protect against cancerous sun rays so that your daily skin care routine can also help promote your daily good health.”

Likewise Skincare was created by board-certified dermatologist and President of Likewise, Inc., Dr. Julie Pena. Likewise daily moisturizers are all-in-one but not one-fits-all. Each moisturizer is made with skin-balancing toners that work with your unique skin type. The moisturizers use a combination of anti-aging antioxidants, ultra-protective zinc oxide and water-resistant ingredients to make sure you're protected.

#####

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10042389.htm

View Comments and Join the Discussion!